Progyny (PGNY) Payables (2018 - 2026)

Progyny (PGNY) has reported Payables for 9 consecutive years, with $152.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 8.21% year-over-year to $152.0 million in Q2 2026; TTM through Jun 2026 was $152.0 million, a 8.21% increase from a year earlier, with the FY2025 full-year figure at $124.1 million, up 30.47% from the prior year.
• Payables was $152.0 million for Q2 2026 at Progyny, down from $157.8 million in the prior quarter.
• Over five years, Payables peaked at $157.8 million in Q1 2026 and troughed at $84.7 million in Q1 2022.
• A 5-year average of $126.4 million and a median of $130.2 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables surged 87.94% in 2022 and decreased 24.18% in 2024, its largest moves.
• Over 5 years, Payables stood at $109.3 million in 2022, then advanced by 14.77% to $125.4 million in 2023, then slipped by 24.18% to $95.1 million in 2024, then soared by 30.47% to $124.1 million in 2025, then climbed by 22.55% to $152.0 million in 2026.
• The last three Payables figures came in at $152.0 million (Q2 2026), $157.8 million (Q1 2026), and $124.1 million (Q4 2025), per Business Quant data.